The creation and progress of the J Project in Eastern and Central Europe

Annals of the New York Academy of Sciences

Volumn 1238, Issue 1, 2011, Pages 65-73

  Maródi, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Genetic technologies; Network; Primary immunodeficiency; Socioeconomic conditions

Indexed keywords

ALLERGIC DISEASE; ARTICLE; AUTOIMMUNE DISEASE; AWARENESS; CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; DIAGNOSTIC TEST; EASTERN EUROPE; GENE IDENTIFICATION; GENE SEQUENCE; GENE TECHNOLOGY; HUMAN; HUMAN GENETICS; IMMUNE DEFICIENCY; KNOWLEDGE; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL SOCIETY; MOLECULAR GENETICS; MONOGENIC DISORDER; PATIENT CARE; PHYSICIAN; PRIMARY IMMUNODEFICIENCY; RESEARCH; SOCIOECONOMICS;

EID: 82555165256     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06247.x     Document Type: Article

References (86)

1. Fischer, A. 2007. Human primary immunodeficiency diseases. Immunity 6: 835-845.
2. Casanova, J.L. & L. Abel. 2007. Primary immunodeficiencies: a field in its infancy. Science 317: 617-619.
3. Maródi, L. & L.D. Notarangelo. 2007. Immunological and genetic bases of new primary immunodeficiencies. Nat. Rev. Immunol. 7: 851-861.
4. Bruton, O.C. 1952. Agammaglobulinemia. Pediatrics 9: 722-728.
5. Hitzig, W.H. 2003. The discovery of agammaglobulinemia in 1952. Eur. J. Pediatr. 162: 289-304.
6. Kostmann, R. 1956. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta. Paediatr. 45: S1-S78.
7. Buckley, R.H. 2000. Primary immunodeficiency diseases due to defects in lymphocytes. N. Engl. J. Med. 343: 1313-1323.
8. Fischer, A. 2004. Human primary immunodeficiency diseases: a perspective. Nat. Immunol. 5: 23-30.
9. Casanova, J.L., C. Fieschi, J. Bustamante, et al. 2005. From idiopathic infectious diseases to novel primary immunodeficiencies. J. Allergy Clin. Immunol. 116: 426-430.
10. Bonilla, F.A. & R.S. Geha. 2006. Update on primary immunodeficiency diseases. J. Allergy Clin. Immunol. 117: S435-S441.
11. Bustamante, J., S. Boisson-Dupuis, E. Jouanguy, et al. 2008. Novel primary immunodeficiencies revealed by the investigation of pediatric infectious diseases. Curr. Opin. Immunol. 20: 39-48.
12. Netea, M.G. & J.W. van derMeer. 2011. Immunodeficiency and genetic defects of pattern-recognition receptors. N. Engl. J. Med. 364: 60-70.
13. Notarangelo, L.D., A. Fischer, R. Geha, et al. 2009. Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 124: 1161-1178.
14. Notarangelo, L.D. 2010. Primary immunodeficiencies. J. Allergy Clin. Immunol. 125: S182-S194.
15. Savides, C. & M. Shaker. 2010. More than just infections: an update on primary immunodeficiencies. Curr. Opin. Pediatr. 22: 647-654.
16. Bousfiha, A., C. Picard, S. Boisson-Dupuis, et al. 2010. Primary immunodeficiencies of protective immunity to primary infections. Clin. Immunol. 135: 204-209.
17. Spinney, L. 2009. News feature. Nat. Med. 15: 10-13.
18. Haverkamp, M.H., J.T. van Dissel & S.M. Holland. 2006. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Microbes Infect. 8: 1157-1166.
19. Notarangelo, L.D. & M.C. Peitsch. 1996. CD40Lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol. Today 17: 511-516.
20. Seyama, K., S. Nonoyama, I. Gangsaas, et al. 1998. Mutation of the CD40 ligand and its effect on CD40 ligand expression in patients with X-linked hyper-IgM syndrome. Blood 92: 2421-2434.
21. Gulino, A.V. & L.D. Notarangelo. 2003. Hyper-IgM syndromes. Curr. Opin. Rheumatol. 15: 422-429.
22. Lee, W.I., T.R. Torgerson, M.J. Schumacher, et al. 2005. Molecular analysis of a large cohort of patients with the hyper-immunoglobulin M (IgM) syndrome. Blood 105: 1881-1890.
23. Erdo{double acute}s, M., A. Durandy & L. Maródi. 2005. Genetically acquired class-switch recombination defects: the multi-faced hyper-IgM syndrome. Immunol. Lett. 97: 1-6.
24. Fleischer, T.A. 2006. Primary immune deficiencies: windows into the immune system. Pediatr. Rev. 27: 363-372.
25. Goyal, R., A.C. Bulua, N.P. Nikolay, et al. 2009. Rheumatologic and autoimmune manfestations of primary immunodeficiency diseases. Curr. Opin. Rheumatol. 21: 78-84.
26. Bussone, G. & L. Mouthon. 2009. Autoimmune manifestations in primary immune deificiencies. Autoimmun. Rev. 8: 332-336.
27. Castigli, E. & R.S. Geha. 2006. Molecular basis of common variable immunodeficiency. J. Allergy Clin. Immunol. 117: 740-746.
28. Sumegi, J., M.G. Barnes, S.V. Nestheide, et al. 2011. Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis. Blood 117: e151-e160.
29. Sharfe, N., M. Shahar & C.M. Roifman. 1997. An interleukin-2 receptor gamma chain mutation with normal thymus morphology. J. Clin. Invest. 100: 3036-3043.
30. Glocker, E.O., A. Hennigs, M. Nabavi, et al. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361: 1727-1735.
31. Filipovich, A.H., K. Zhang, A.L. Snow & R.A. Marsh. 2010. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood 116: 3398-3408.
32. McMurchy, A.N., J. Gillies, S.E. Allan, et al. 2010. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells. J. Allergy Clin. Immunol. 126: 1242-1251.
33. Husebye, E.S., J. Perheentupa, R. Rautemaa, et al. 2009. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. J. Intern. Med. 265: 514-529.
34. Tóth, B., A. Wolff, Z. Halász, et al. 2010. Novel sequence variation of AIRE and detection of interferon-ω antibodies in early infancy. Clin. Endocrinol. 72: 641-647.
35. Notarangelo, L.D. & J.L. Casanova. 2009. Primary immunodeficiencies: increasing market share. Curr. Opin. Immunol. 21: 461-465.
36. Fang, C.J., A. Richards, M.K. Liszewski, et al. 2008. Advances in understanding of pathogenesis of aHUS and HELLP. Br. J. Med. 143: 336-348.
37. Suzuki, T., T. Sakagami, B.K. Rubin, et al. 2008. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J. Exp. Med. 205: 2703-2710.
38. Martinez-Moczygemba, M., M.L. Doan, O. Elidemir, et al. 2008. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRα gene in the X chromosome pseudoautosomal region. J. Exp. Med. 205: 2711-2716.
39. Józsi, M. & P. Zipfel. 2008. Factor H family proteins and human diseases. Cell 29: 380-387.
40. Smith, A.M., F.Z. Rahman, B. Hayee, et al. 2009. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 206: 1883-1897.
41. Marks, D.J., F.Z. Rahman, G.W. Sewell & A.W. Segal. 2009. Crohn's disease: an immune deficiency state. Clin. Rev. Allergy Immunol. 38: 20-31.
42. Casanova, J.L. & L. Abel. 2009. Revisiting Crohn's disease as a primary immunodeficiency of macrophages. J. Exp. Med. 206: 1839-1843.
43. Kitamura, T., N. Tanaka, J. Watanabe, et al. 1999. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 190: 875-880.
44. Notarangelo, L.D. & I. Pessach. 2008. Out of breath: GM-CSFRalpha mutations disrupt surfactant homeostasis. J. Exp. Med. 205: 2693-2697.
45. Maródi, L. & J.L. Casanova. 2009. Novel primary immunodeficiencies relevant to internal medicine: novel phenotypes. J. Intern. Med. 266: 502-506.
46. Vajdic, C.M., L. Mao, M.T. van Leeuwen, et al. 2010. Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency? Blood 116: 1228-1223.
47. Erdos, M., M. Garami, E. Rákóczi, et al. 2008. Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature. Clin. Immunol. 129: 455-461.
48. Cárdenes, M., A. Angel-Moreno, C. Fieschi, et al. 2010. Oesophageal squamous cell carcinoma in a young adult with IL-12R beta 1 deficiency. J. Med. Genet. 47: 635-640.
49. Pastorczak, A., M. Stolarska, J. Trelińska, et al. 2011. Nijmegen breakage syndrome (NBS) as a risk factor for CNS involvement in childhood acute lymphoblastic leukemia. Pediatr. Blood Cancer 57: 160-162.
50. Perlman, S.L., E. Boder, R.P. Sedgewick & R.A. Gatti. 2011. Ataxia-telangiectasia. Handb. Clin. Neurol. 103: 307-332.
51. Maródi, L. & J.L. Casanova. 2010. Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies? Nat. Rev. Immunol. 10: 299-300.
52. Maródi, L. & J.L. Casanova. 2010. Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting monoclonal antibody treatments J. Allergy Clin. Immunol. 126: 910-917.
53. Shearer, W.T. 2005. Infection versus immunity: what's the balance? J. Allergy Clin. Immunol. 116: 263-266.
54. Bonilla, F.A. & Geha, R.S. 2005. Are you immunodeficient? J. Allergy Clin. Immunol. 116: 423-425.
55. Alapi, K., M. Erdõs, O. Török & L. Maródi. 2006. Prenatal diagnosis of the WAS R86H sequence variation in heterozygous twins. Clin. Chem. 52: 901-903.
56. Mazza, C., F. Buzi, F. Ortolani, et al. 2011. Clinical heterogeneity and diagnostic delay of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome. Clin. Immunol. 139: 6-11.
57. Erdõs, M., B. Tóth, I. Veres, et al. 2011. Nijmegen breakage syndrome complicated with primary cutaneous tuberculosis. Pediatr. Infect. Dis. J. 30: 359-360.
58. Kriván, G., M. Erdõs, K. Kállay, et al. 2010. Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome. Eur. J. Haematol. 84: 274-275.
59. Jiao, H., B. Tóth, M. Erdõs, et al. 2008. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol. Immunol. 46: 202-206.
60. Erdõs, M., K. Alapi & L. Maródi. 2007. Retrospective diagnosis of X-linked hyper-IgM syndrome in a family with multiple deaths of affected males. Haematologica 92: 281-282.
61. Alapi, K., M. Erdõs & L. Maródi. 2007. Recurrent CXCR4 sequence variation in a girl with incomplete WHIM syndrome. Eur. J. Haematol. 78: 86-88.
62. Kellermayer, R., A.P. Hsu, J. Stankovics, et al. 2006. A novel IL2RG mutation associated with maternal T lymphocyte engraftment in a patient with severe combined immunodeficiency. J. Hum. Genet. 51: 495-497.
63. Erdõs, M., K. Alapi, I. Balogh, et al. 2006. Severe Shwachman-Diamond syndrome phenotype caused by missense mutation in the SBDS gene. Exp. Hematol. 34: 1517-1521.
64. Tuzankina, I., Y. Kobeleva, N. Kiseleva, et al. 2011. Cytotoxic T lymphocytes mediate neuronal injury in patients with X-linked agammaglobulinemia and progressive neurodeneretative disease. Allergy. doi:.
65. Simon, G., G. Simon, M. Erdõs & L. Maródi. 2005. Invasive Cryptococcus laurentii disease in a 9-year-old boy with X-linked hyper-immunoglobulin M syndrome. Pediatr. Infect. Dis. J 24: 935-937.
66. Puck, J.M. 2007. Neonatal screening for severe combined immune deficiency. Curr. Opin. Allergy Clin. Immunol. 7: 522-527.
67. Azzari, C., G. la Marca & M. Resti. 2011. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry. J. Allergy Clin. Immunol. 127: 1394-1399.
68. Boztug, K., M. Schmidt, A. Schwarzer, et al. 2010. Correction of Wiskott-Aldrich syndrome by hematopoietic stem cell gene therapy. N. Engl. J. Med. 363: 1918-1927.
69. Cavazzana-Calvo, M. & A. Fischer. 2007. Gene therapy for severe combined immunodeficiency: are we there yet? J. Clin. Invest. 117: 1456-1465.
70. Gaspar, H.B., K.L. Parsley, S. Howe, et al. 2004. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187.
71. Ferrua, F., I. Brigida & A. Aiuti. 2010. Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency. Curr. Opin. Allergy. Clin. Immunol. 10: 551-556.
72. Sanger, F., S. Nicklen & A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. 74: 5463-5467.
73. Mardis, E.R. 2011. A decade's perspective on DNA sequencing technology. Nature 470: 198-203.
74. Puel, A., S. Cypowyj, J. Bustamante, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65-68.
75. Liu, L., S. Okada, X.F. Kong, et al. 2011. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208: 1635-1648.
76. van de Veerdonk, F.L., T.S. Plantinga, A. Hoischen, et al. 2011. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365: 54-61.
77. Bolze, A., et al. 2010. Whole-exome-sequencing-based discovery of human FADD deficiency. Am. J. Hum. Genet. 87: 873-881.
78. Byun, M., et al. 2010. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J. Exp. Med. 207: 2307-2312.
79. Maródi, L. & J.L. Casanova. 2009. Primary immunodeficiency diseases: the J Project. Lancet 373: 2179-2181.
80. Maródi, L. & L.D. Notarangelo. 2007. Education and worldwide collaboration pays off. Nat. Immunol. 8(4): 323-324.
81. Modell, F., D. Puente & V. Modell. 2009. From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies. Immunol. Res. 44: 132-149.
82. Pickett, D., V. Modell, I. Leighton & F. Modell. 2008. Impact of a physician education and patient awareness campaign on the diagnosis and management of primary immunodeficiencies. Immunol. Res. 40: 93-94.
83. Carneiro-Sampaio, M., M.A. Jacob & C.R. Leone. 2011. A proposal of warning signs of primary immunodeficiencies in the first year of life. Pediatr. Allergy Immunol. 22: 345-346.
84. Gulácsy, V., T. Freiberger, A. Shcherbina, et al. 2011. Genetic characteristics of eighty-seven patients with the Wiskott-Aldrich syndrome. Mol. Immunol. 48: 788-792.
85. Tóth, B., A. Volokha, A. Mihas, et al. 2009. Genetic and demographic features of X-linked agammaglobulinemia in Eastern and Central Europe: a cohort study. Mol. Immunol. 6: 2140-2146.
86. Mellemkjaer, L., L. Hammarstrom, V. Andersen, et al. 2002. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin. Exp. Immunol. 130: 495-500.